Canertinib dihydrochloride
Jump to navigation
Jump to search
| Canertinib dihydrochloride | |
|---|---|
| Term | Canertinib dihydrochloride |
| Short definition | Canertinib dihydrochloride - (pronounced) (can-ER-tih-nib dy-HY-droh-KLOR-ide) substance being studied to treat some types of cancer. Canertinib dihydrochloride blocks the action of proteins called epidermal growth factor receptors and can cause cancer cells to die. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
Canertinib dihydrochloride - (pronounced) (can-ER-tih-nib dy-HY-droh-KLOR-ide) substance being studied to treat some types of cancer. Canertinib dihydrochloride blocks the action of proteins called epidermal growth factor receptors and can cause cancer cells to die. It's a type of tyrosine kinase inhibitor. Also called CI-1033
External links
- Medical encyclopedia article on Canertinib dihydrochloride
- Wikipedia's article - Canertinib dihydrochloride
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski